Tiong Xun Ting on Battling MDR-TB

Challenges to diagnosis and treatment



CPTR: Workshop 2016 Highlights

Washington DC, April 4-7


Christian Lienhardt on TB-PACTS Database

Aggregating and sharing data from multiple clinical trials can yield new insight.


CPTR: Accelerating a new paradigm

Perspectives on the urgency of CPTR’s mission and ongoing efforts



2017 CPTR Annual Workshop to be Held March 20 – 23 in Washington DC

The 2017 Critical Path to TB Drug Regimens (CPTR) Annual Workshop, will be held March 20-23, 2017, in Washington DC. DATE: Monday, March 20 through Thursday, March 23, 2017 LOCATION: Washington, DC – Washington Marriot at Metro Center | 775 12th Street NW | 20005 Engaging panel sessions are being developed to showcase the exciting […]

October 12, 2016 Drug Development Events RDST Regulatory Science Research Resources Assay Development CPTR Workshop 2017 drug development

9th International Workshop on Pharmacology of TB Drugs – October 24th in Liverpool

The 9th edition of the International Workshop on Pharmacology of Tuberculosis Drugs will be held on 24 October 2016 in Liverpool, United Kingdom, preceding the Union World Conference on Lung Health 2016. The aim of this abstract-driven workshop is to make a significant contribution to the optimization of TB treatment, by bringing experts together and […]

October 12, 2016 Drug Development Events clinical trials drug development IUATLD Conference pharmacology

From the Working Groups

Modeling & Simulation Workgroup (M&S-WG) Q4-2015 Update

Working closely with the Data Standards and Integration Workgroup (DSI-WG), the M&S-WG uses aggregated clinical trial data to create robust empirical, mechanistic, and systems biology models and quantitative simulation tools to facilitate TB drug and drug regimen development.

January 22, 2016

Data Standards & Integration Workgroup (DSI-WG) Q4-2015 Update

The DSI-WG provides the information technology (IT) infrastructure to support all CPTR data needs for developing regulatory science tools and methods to enable development of new TB drugs, drug regimens, and diagnostics. Aggregating all relevant data in a secure database for analysis by the CPTR Workgroups and authorized researchers is a key focus for this […]

January 22, 2016

Pre-Clinical and Clinical Sciences Workgroup (PCS-WG) Q4-2015 Update

The PCS-WG is focused on the evidence-based evaluation of translational tools to support effective decision-making and advance new agents from the pre-clinical to clinical development space.  These tools represent innovative approaches to address pre-clinical issues, including pre-clinical in vitro and in vivo efficacy, pre-clinical drug safety, and toxicology, pre-clinical PK/PD analyses involving the use of […]

January 22, 2016
About CPTR

Through partnership, CPTR speeds the development of new and markedly improved drug regimens for tuberculosis.